Pancreatic cancer screening
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer screening On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer screening |
|
Risk calculators and risk factors for Pancreatic cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Screening
- In the general population, screening of large groups is not currently considered effective, although newer techniques, and the screening of tightly targeted groups, are being evaluated.[1][2] Nevertheless, regular screening with endoscopic ultrasound and MRI/CT imaging is recommended for pancreatic cancer in high risk individuals.
- Individuals with the following conditions are also at an increased risk of pancreatic cancer:[3]
- Hereditary pancreatitis
- Familial pancreatic cancer
- Peutz-Jeghers disease
- Familial atypical mole melanoma syndrome (FAMMM)
- Cystic fibrosis of pancreas,
- Familial cancer syndromes such as:
- Lynch syndrome
- Familial adenomatous polyposis (FAP)
- von Hippel-Lindau syndrome
- Multiple endocrine neoplasia type 1
- Hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations
References
- ↑ He XY, Yuan YZ (August 2014). "Advances in pancreatic cancer research: moving towards early detection". World J. Gastroenterol. 20 (32): 11241–8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
- ↑ Okano K, Suzuki Y (August 2014). "Strategies for early detection of resectable pancreatic cancer". World J. Gastroenterol. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
- ↑ Goral V (2015). "Pancreatic Cancer: Pathogenesis and Diagnosis". Asian Pac J Cancer Prev. 16 (14): 5619–24. PMID 26320426.